5:05 PM
 | 
Aug 06, 2013
 |  BC Extra  |  Company News

Rumors of upped Amgen bid for Onyx

Amgen Inc. (NASDAQ:AMGN) and cancer company Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) declined to comment on media reports that Amgen raised its bid...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >